Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;117(1):70-6.
doi: 10.1016/j.ygyno.2009.12.030. Epub 2010 Jan 27.

Knowledge of cervical cancer prevention and human papillomavirus among women with HIV

L Stewart Massad  1 , Charlesnika T Evans, Tracey E Wilson, Johanna L Goderre, Nancy A Hessol, Donna Henry, Christine Colie, Howard D Strickler, Alexandra M Levine, D Heather Watts, Kathleen M Weber
Affiliations

Knowledge of cervical cancer prevention and human papillomavirus among women with HIV

L Stewart Massad et al. Gynecol Oncol. 2010 Apr.

Abstract

Objective: To assess knowledge of and attitudes towards human papillomavirus (HPV), Pap testing, and the HPV vaccine.

Methods: In a multicenter U.S. cohort study, women with the human immunodeficiency virus (HIV) and at-risk comparison women completed 44-item standardized self-report questionnaires exploring their knowledge of cervical cancer prevention, HPV, and HPV vaccination. Results were correlated with demographic variables, measures of education and attention, and medical factors. Data were clustered using principal component analysis. Significant associations were assessed in multivariable models.

Results: Among 1588 women, HIV seropositive women better understood facts about cervical cancer prevention and HPV than seronegative women, but both had substantial knowledge deficits. Almost all women considered Pap testing important, although 53% of HIV seropositive and 48% of seronegative women considered cervical cancer not preventable (P=0.21). Only 44% of HIV seropositive women knew Paps assess the cervix, versus 42% of HIV seronegative women (P=0.57). Both groups understood that HPV causes genital warts and cervical cancer (67% of HIV seropositive vs. 55% of seronegative women, P=0.002). About half of both groups considered HPV vaccination extremely important for cervical cancer prevention. HIV seronegative women were more likely to report learning of HPV vaccination through advertising than from clinicians (81% vs. 64%, P<0.0001).

Conclusion: High risk women need effective education about cervical cancer prevention, HPV, and HPV vaccination.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

The authors declare that there are no conflicts of interest.

References

    1. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus (HIV) positive women. J Natl Cancer Inst. 2005;97:577–86. - PubMed
    1. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW the New York Cervical Disease Study. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol. 1994;84:591–7. - PubMed
    1. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, et al. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with human immunodeficiency virus-1. J Acquire Immun Deficiency Syndromes Hum Retrovirol. 1999;21:33–41. - PubMed
    1. Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the Women’s Interagency HIV Study. J Acquir Immunodef Human Retrovirol. 2001;27:432–42. - PubMed
    1. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92:1500–10. - PubMed

Publication types

MeSH terms

Substances